BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published Sep.19, 2024! The future of Cancer Treatment starts now.
This study by Drs. William Makis, Paul Marik, et al. presents a promising treatment modality using repurposed, FDA-approved drugs with excellent safety profiles and few (if any) side effects. I know from my conversations with Dr. Marik--and from reading his book, "Cancer Care: The Role of Repurposed Drugs and Metabolic Interventions in Treating Cancert"--that he has has been researching this domain with extreme care and diligence. I believe that this study may open up an entirely new vista on our understanding of cancer and how to treat it. It also strikes me as one of the most fascinating phenomenon in nature that the soil bacterium Streptomyces avermitilis produces a molecule that seems to suppress the growth of human cancer cells. What a wondrous thing is nature! -
Subscribe to COVID Intel - by Dr.William Makis to continue reading
Head to the author’s Substack to subscribe and keep reading.